References
- Stagno S, Pass RF, Dworsky ME, Henderson RE, Moore EG, Walton PD, Congenital cytomegalovirus infection: the relative importance of primary and recurrent maternal infection. N Engl J Med 1982;306:945–9.
- Williamson WD, Demmler GJ, Percy AK, Catlin FI. Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection. Pediatrics 1992;90:862–6.
- Noyola DE, Demmler GJ, Williamson WD, Griesser C, Sellers S, Llorente A, Cytomegalovirus urinary excretion and long term outcome in children with congenital cytomegalovirus infection. Congenital CMV Longitudinal Study Group. Pediatr Infect Dis J 2000;19:505–10.
- Morton CC, Nance WE. Newborn hearing screening – a silent revolution. N Engl J Med 2006;354:2151–64.
- Fowler KB, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 1997;130:624–30.
- Ogawa H, Suzutani T, Baba Y, Koyano S, Nozawa N, Ishibashi K, Etiology of severe sensorineural hearing loss in children: independent impact of congenital cytomegalovirus infection and GJB2 mutations. J Infect Dis 2007;195:782–8.
- Denoyelle F, Marlin S, Weil D, Moatti L, Chauvin P, Garabedian EN, Clinical features of the prevalent form of childhood deafness, DFNB1, due to a connexin-26 gene defect: implications for genetic counselling. Lancet 1999;353:1298–303.
- Abe S, Usami S, Shinkawa H, Kelley PM, Kimberling WJ. Prevalent connexin 26 gene (GJB2) mutations in Japanese. J Med Genet 2000;37:41–3.
- Fukushima K, Sugata K, Kasai N, Fukuda S, Nagayasu R, Toida N, Better speech performance in cochlear implant patients with GJB2-related deafness. Int J Pediatr Otorhinolaryngol 2002;62:151–7.
- Sinnathuray AR, Toner JG, Clarke-Lyttle J, Geddis A, Patterson CC, Hughes AE. Connexin 26 (GJB2) gene-related deafness and speech intelligibility after cochlear implantation. Otol Neurotol 2004;25:935–42.
- Lee DJ, Lustig L, Sampson M, Chinnici J, Niparko JK. Effects of cytomegalovirus (CMV) related deafness on pediatric cochlear implant outcomes. Otolaryngol Head Neck Surg 2005;133:900–5.
- Iwasaki S, Nakanishi H, Misawa K, Tanigawa T, Mizuta K. Cochlear implant in children with asymptomatic congenital cytomegalovirus infection. Audiol Neurootol 2009;14:146–52.
- Yoshida H, Kanda Y, Takahashi H, Miyamoto I, Yamamoto T, Kumagami H. Cochlear implantation in children with congenital cytomegalovirus infection. Otol Neurotol 2009;30:725–30.
- Daneshi A, Hassanzadeh S. Cochlear implantation in prelingually deaf persons with additional disability. J Laryngol Otol 2007;121:635–8.
- Donaldson AI, Heavner KS, Zwolan TA. Measuring progress in children with autism spectrum disorder who have cochlear implants. Arch Otolaryngol Head Neck Surg 2004;130:666–71.
- Pundir M, Nagarkar AN, Panda NK. Intervention strategies in children with cochlear implants having attention deficit hyperactivity disorder. Int J Pediatr Otorhinolaryngol 2007;71:985–8.
- Ogawa H, Baba Y, Suzutani T, Inoue N, Fukushima E, Omori K. Congenital cytomegalovirus infection diagnosed by polymerase chain reaction with the use of preserved umbilical cord in sensorineural hearing loss children. Laryngoscope 2006;116:1991–4.
- Waltzman SB, Scalchunes V, Cohen NL. Performance of multiply handicapped children using cochlear implants. Am J Otol 2000;21:329–35.
- Wiley S, Jahnke M, Meinzen-Derr J, Choo D. Perceived qualitative benefits of cochlear implants in children with multi-handicaps. Int J Pediatr Otorhinolaryngol 2005;69:791–8.